"As a 484-bed acute care medical center located on the Buffalo Niagara Medical Campus in downtown Buffalo, NY, BGMC/GVI provides the latest treatment options, technology and expert physicians."

During the past decade, University at Buffalo/Buffalo General Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University at Buffalo/Buffalo General Medical Center" #1 sponsor was "State University of New York at Buffalo" with 2 trials, followed by "Mesoblast, Inc." with 1 trials sponsored, "Michael Benatar" with 1 trials sponsored, "University at Buffalo" with 1 trials sponsored and "Vanderbilt University Medical Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University at Buffalo/Buffalo General Medical Center" #1 collaborator was "Dolly Parton" with 1 trials as a collaborator, "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator, "University of Miami" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University at Buffalo/Buffalo General Medical Center" are "Bariatric Surgery Candidate" (1 trials), "COVID-19" (1 trials), "Cirrhosis" (1 trials), "Coronavirus" (1 trials) and "Fatty Liver" (1 trials). Many other conditions were trialed in "University at Buffalo/Buffalo General Medical Center" in a lesser frequency.

Most popular intervention types in "University at Buffalo/Buffalo General Medical Center" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mayzent" (1 trials), "Ocrevus" (1 trials), "Prednisone" (1 trials) and "Prochymal®" (1 trials). Other intervention names were less common.

The vast majority of trials in "University at Buffalo/Buffalo General Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University at Buffalo/Buffalo General Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University at Buffalo/Buffalo General Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University at Buffalo/Buffalo General Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".